Abstract:Background: The process of optimization and fabrication of nanoparticle synthesis for preclinical studies can be challenging and time consuming. Traditional small scale laboratory synthesis techniques suffer from batch to batch variability. Additionally, the parameters used in the original formulation must be re-optimized due to differences in fabrication techniques for clinical production. Several low flow microfluidic synthesis processes have been reported in recent years for developing nanoparticles that are a hybrid between polymeric nanoparticles and liposomes. However, use of high flow microfluidic synthetic techniques has not been described for this type of nanoparticle system, which we will term as nanolipomer. In this manuscript, we describe the successful optimization and functional assessment of nanolipomers fabricated using a microfluidic synthesis method under high flow parameters. Results: The optimal total flow rate for synthesis of these nanolipomers was found to be 12 ml/min and flow rate ratio 1:1 (organic phase: aqueous phase). The PLGA polymer concentration of 10 mg/ml and a DSPE-PEG lipid concentration of 10% w/v provided optimal size, PDI and stability. Drug loading and encapsulation of a representative hydrophobic small molecule drug, curcumin, was optimized and found that high encapsulation efficiency of 58.8% and drug loading of 4.4% was achieved at 7.5% w/w initial concentration of curcumin/PLGA polymer. The final size and polydispersity index of the optimized nanolipomer was 102.11 nm and 0.126, respectively. Functional assessment of uptake of the nanolipomers in C4-2B prostate cancer cells showed uptake at 1 h and increased uptake at 24 h. The nanolipomer was more effective in the cell viability assay compared to free drug. Finally, assessment of in vivo retention in mice of these nanolipomers revealed retention for up to 2 h and were completely cleared at 24 h. Conclusions: In this study, we have demonstrated that a nanolipomer formulation can be successfully synthesized and easily scaled up through a high flow microfluidic system with optimal characteristics. The process of developing nanolipomers using this methodology is significant as the same optimized parameters used for small batches could be translated into manufacturing large scale batches for clinical trials through parallel flow systems.

Dialysis-functionalized Microfluidic Platform for in Situ Formation of Purified Liposomes.

Novel 3D Integrated Microfluidic Device: Design, Construction, and Application to the Preparation of Liposomes for Vaccine Delivery

Rapid Production of Nanoscale Liposomes Using a 3D-Printed Reactor-In-A-Centrifuge: Formulation, Characterisation, and Super-Resolution Imaging

One‐Step Formation of Targeted Liposomes in a Versatile Microfluidic Mixing Device

Manufacturing of 3D-Printed Microfluidic Devices for the Synthesis of Drug-Loaded Liposomal Formulations

SPIN: rapid synthesis, purification, and concentration of small drug-loaded liposomes

Preparation of uniform microcapsules with silicone oil as continuous phase in a micro-dispersion process.

3D Printed Integrated Multi-Layer Microfluidic Chips for Ultra-High Volumetric Throughput Nanoliposome Preparation

Continuous Processing of Phase-Change Materials into Uniform Nanoparticles for Near-Infrared-triggered Drug Release

Preparation of microcapsules containing ionic liquids with a new solvent extraction system

Scalable Production of Biomedical Microparticles via High-Throughput Microfluidic Step Emulsification

Gravity-Oriented Microfluidic Device for Biocompatible End-to-End Fabrication of Cell-Laden Microgels.

Development of a Microfluidic-Based Post-Treatment Process for Size-Controlled Lipid Nanoparticles and Application to siRNA Delivery

Precise Fabrication of Porous Microspheres by Iso-Density Emulsion Combined with Microfluidics

Fabrication and Characterizations of a Novel Drug Delivery Device Liposomes-in-microsphere (LIM).

High throughput microfluidics-based synthesis of PEGylated liposomes for precise size control and efficient drug encapsulation

Production of liposomes by microfluidics: The impact of post-manufacturing dilution on drug encapsulation and lipid loss

Optimization and scale up of microfluidic nanolipomer production method for preclinical and potential clinical trials

Effect of Micromixer Design on Lipid Nanocarriers Manufacturing for the Delivery of Proteins and Nucleic Acids

Establishment of a semi-continuous nano-production line using the Microfluidizer® technology for the fabrication of lipid-based nanoparticles part 1: Screening of critical parameters and design of experiment optimization studies

Utilization of cell-sized lipid containers for nanostructure and macromolecule handling in microfabricated devices